Innovent Biologics, Inc. announces the establishment of Scientific Advisory Board (SAB). The SAB is to provide scientific advices to research and clinical pipelines that fulfills the mission and vision of Innovent along with the global reach to benefit patients worldwide. This SAB comes together with three world renowned scientists, including: Professor Dr. Lewis L. Lanier, an American Cancer Society Professor and J. Michael Bishop MD Distinguished Professor and Chairman of Microbiology and Immunology at University of California San Francisco and Director of the Parker Institute for Cancer Immunotherapy, and elected to the US National Academy of Sciences (2010), and the American Academy of Arts and Sciences (2011). Dr. Lanier serves the chairman of the SAB. Professor Dr. Lawrence Fong, the Efim Guzik Distinguished Professor in Cancer Biology in the Helen Diller Family Comprehensive Cancer Center at the University of California San Francisco and co-director of the Parker Institute of Cancer Immunotherapy. Dr. Carlos Garcia-Echeverria, an accomplished drug discovery scientist and pharma executive, bringing 25+ years experiences from EQRx, Sanofi and Novartis.